[1]罗淞元,李小霞,王喜梅.脉搏指示连续心排出量监测在脓毒症急性肾损伤治疗中的应用价值[J].新乡医学院学报,2018,35(3):231-234.[doi:10.7683/xxyxyxb.2018.03.018]
　LUO Song-yuan,LI Xiao-xia,WANG Xi-mei.Clinical value of pulse indicator continuous cardiac output monitoring in treating acute kidney injury due to sepsis[J].Journal of Xinxiang Medical University,2018,35(3):231-234.[doi:10.7683/xxyxyxb.2018.03.018]
点击复制

脉搏指示连续心排出量监测在脓毒症急性肾损伤治疗中的应用价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年3
页码:
231-234
栏目:
临床研究
出版日期:
2018-03-05

文章信息/Info

Title:
Clinical value of pulse indicator continuous cardiac output monitoring in treating acute kidney injury due to sepsis
作者:
罗淞元; 李小霞; 王喜梅
（驻马店市中心医院ICU，河南　驻马店　463000）
Author(s):
LUO Song-yuan; LI Xiao-xia; WANG Xi-mei
（Department of Intensive Care Unit，the Central Hospital of Zhumadian，Zhumadian 463000，Henan Province，China）
关键词:
连续心排出量; 脓毒症; 脓毒性休克; 肾损伤
Keywords:
continuous cardiac output; sepsis; septic shock; kidney injury
分类号:
R631
DOI:
10.7683/xxyxyxb.2018.03.018
文献标志码:
A
摘要:
目的　评价脉搏指示连续心排出量监测在脓毒症急性肾损伤（AIK）治疗中的临床应用效果。方法　选择驻马店市中心医院2013年8月至2016年8月收治的62例脓毒性休克并发AKI患者为研究对象，根据是否应用脉搏指示连续心排出量监测将患者分为对照组（34例）和观察组（28例）。对2组患者液体复苏6、24 h后的复苏液体量、心率（HR）、中心静脉压（CVP）、平均动脉压（MAP）、血管活性药物用量等指标进行观察，比较2组患者的持续肾脏替代治疗时间、日滤过量及治疗7 d后的自主尿量、血肌酐水平及存活率。结果　2组患者液体复苏6 h后的HR、CVP及MAP比较差异均无统计学意义（P>0.05）。液体复苏24 h后，对照组患者的HR与液体复苏6 h后比较差异无统计学意义（P>0.05），CVP和MAP高于液体复苏6 h后（P<0.05）；观察组患者的HR低于液体复苏6 h后（P<0.05），MAP高于液体复苏6 h后（P<0.05），CVP与液体复苏6 h后比较差异无统计学意义（P>0.05）。液体复苏 24 h 后，观察组患者的HR和CVP显著低于对照组（P<0.05），2组患者MAP比较差异无统计学意义（P>0.05）。2组患者液体复苏6 h后的复苏液体量及去甲肾上腺素、多巴酚丁胺用量比较差异无统计学意义（P>0.05）。液体复苏24 h后，观察组患者的复苏液体量、多巴酚丁胺用量显著少于对照组（P<0.05）。观察组患者的持续肾脏替代治疗时间、日滤过量及治疗7 d后血肌酐水平显著低于对照组（P<0.05），而治疗7 d后自主尿量显著高于对照组（P<0.05）。治疗7 d后，对照组患者存活28例，存活率为82.4%（28/34）；观察组患者存活25例，存活率为89.3%（25/28）；治疗7 d后2组患者存活率比较差异无统计学意义（χ2=0.59，P>0.05）。结论　脓毒症AKI患者在液体复苏过程中采用脉搏指示连续心排出量监测能够优化液体管理，促进患者肾功能恢复。
Abstract:
Objective　To evaluate the clinical value of pulse indicator continuous cardiac output monitoring in treating acute kidney injury（AKI） due to sepsis.Methods　Sixty-two patients with AKI due to sepsis in the Central Hospital of Zhumadian from August 2013 to August 2016 were rolled in and divided into control group （34 cases） and observation group （28 cases） according to whether adopted pulse indicator continuous cardiac output monitoring.Six hours and 24 hours after fluid resuscitation，resuscitation fluid volume，heart rate（HR），central venous pressure（CVP），mean arterial pressure（MAP），vasoactive drugs dose of the two groups were observed.Treatment times，daily filtration volume of continuous renal replacement therapy and independent urine volume，serum creatinine level，the survival rate after treating for seven days in the two groups were compared.Results　There was no significant difference in the HR, central venous pressure, mean arterial pressure at six hours after fluid resuscitation between the two groups（P>0.05）. At 24 hours after fluid resuscitation, there was no significant difference in the HR in the control group compared with that at six hours after fluid resuscitation（P>0.05），the CVP and MAP were higher than those at six hours after fluid resuscitation（P<0.05）；the HR in the observation group was lower than that at six hours after fluid resuscitation（P<0.05），MAP was higher than that at six hours after fluid resuscitation（P<0.05），but there was no significant difference in the CVP in the control group compared with that at six hours after fluid resuscitation（P>0.05）.The HR and CVP at 24 hours after fluid resuscitation in the observation group were lower than those in the control group（P<0.05），while there was no no significant difference in the MAP between the two groups（P>0.05）.There was no significant difference in the fluid resuscitation volume，the dose of noradrenaline and dobutamine after treating for six hours between the two groups(P>0.05). Twenty four hours after fluid resuscitation resuscitation fluid volume and dobutamine dose in the observation group were significantly lower than those in the control group (P<0.05). The duration of renal replacement therapy, the daily filtration volume and the blood creatinine after treating for seven days in the observation group were significantly lower than those in the control group (P<0.05), but the independent urine volume after treating for seven days in the observation group was significantly higher than that in the control group (P<0.05). After treating for seven days,there were 28 cases survival, the survival rate was 82.4%（28/34）,while there were 25 cases survival，the survival rate was 89.3%（25/28）；the difference of survival rate between the two groups was not statistically significant (χ2=0.59,P>0.05).Conclusion　In patients with AKI due to sepsis，pulse indicator continuous cardiac output monitoring can be used to optimize fluid management，and it can improved the renal function.

参考文献/References:

［1］　武宇辉，齐颖，马伟科，等.微小RNA-155和微小RNA-21对脓毒症患儿Toll样受体4表达的影响［J］.中华实用儿科临床杂志，2017，32（6）:420-424.
［2］　李亚萍，张俊林.降钙素原、胆碱酯酶及心肌肌钙蛋白Ⅰ在脓毒症患者病情及预后评估中的应用价值［J］.新乡医学院学报，2017，34（12）:1111-1113.
［3］　孙杭，张宪伟，潘伟，等.补体消耗与脓毒症患儿病情严重程度的相关性［J］.中华实用儿科临床杂志，2017，32（6）:425-429.
［4］　黄昭，王思荣，刘继云，等.血液灌流治疗对脓毒症急性肾损伤患者炎症因子的清除及肾脏保护作用［J］.中华急诊医学杂志，2011，20（1）:60-64.
［5］　郭应军，孟繁甦，王国军，等.脉搏指示连续心排出量技术在重症肺炎患者液体管理中的作用［J］.中国医药，2013，8（3）:332-334.
［6］　王海波，徐丽娟，李克鹏，等.KDIGO标准APACHEⅡ与SOFA评分对脓毒症急性肾损伤患者的预后评估［J］.中国急救医学，2013，33（6）:499-502.
［7］　许煊.聚焦儿童脓毒症的治疗进展［J］.中华实用儿科临床杂志，2017，32（6）:401-403.
［8］　苏军，金志鹏，王琪，等.不同液体复苏对脓毒症患儿肾功能的影响［J］.中华实用儿科临床杂志，2016，31（13）:1005-1008.
［9］　方海云，唐华平.血必净对严重脓毒血症患者血流动力学和乳酸值的影响［J］.深圳中西医结合杂志，2016，26（7）:39-41.
［10］　袁静，陈勇，马勇，等.感染性休克患者下腔静脉管径及塌陷指数与PiCCO血流动力学指标的相关性［J］.实用临床医药杂志，2016，20（15）:21-23，32.
［11］　卢露，潘国权，汤鲁明，等.PICCO指导下液体复苏对脓毒症休克患者免疫功能及炎症介质的影响［J］.中华全科医学，2017，15（4）:562-564.
［12］　秦学东，王泉利，刘鹏飞，等.PiCCO监测指导严重脓毒症合并肺损伤患者液体管理的临床研究［J］.临床和实验医学杂志，2017，16（7）:699-702.

相似文献/References:

[1]张　亮,刘万周,程　涛.降钙素原和急性生理与慢性健康评分Ⅱ对脓毒症患者预后的评估[J].新乡医学院学报,2016,33(7):629.[doi:10.7683/xxyxyxb.2016.07.022]
　ZHANG Liang,LIU Wan-zhou,CHENG Tao.Evaluation of procalcitonin and acute physiology and chronic health evaluation Ⅱ on the prognosis of sepsis patients[J].Journal of Xinxiang Medical University,2016,33(3):629.[doi:10.7683/xxyxyxb.2016.07.022]
[2]韩晓红,田　静,邢学勇.生长抑素对老年脓毒症患者肠黏膜屏障功能的保护作用[J].新乡医学院学报,2019,36(8):789.[doi:10.7683/xxyxyxb.2019.08.021]
　HAN Xiao-hong,TIAN Jing,XING Xue-yong.Protective effect of somatostatin on intestinal mucosal barrier function in elderly patients with sepsis[J].Journal of Xinxiang Medical University,2019,36(3):789.[doi:10.7683/xxyxyxb.2019.08.021]
[3]崔利丹,金志鹏,苏　军,等.脓毒症患者血清中炎性因子、组织因子和组织因子途径抑制物水平变化及临床意义[J].新乡医学院学报,2019,36(1):071.[doi:10.7683/xxyxyxb.2019.01.015]
　CUI Li-dan,JIN Zhi-peng,SU Jun,et al.Changes and clinical significance of serum levels of inflammatory factors，tissue factor and tissue factor pathway inhibitor in patients with sepsis[J].Journal of Xinxiang Medical University,2019,36(3):071.[doi:10.7683/xxyxyxb.2019.01.015]
[4]王光权,李　洪,潘在轩.微RNA-204靶向硫氧还蛋白相互作用蛋白对脓毒症大鼠急性肺损伤的保护作用[J].新乡医学院学报,2021,38(7):612.[doi:10.7683/xxyxyxb.2021.07.003]
　WANG Guangquan,LI Hong,PAN Zaixuan.Protective effect of microRNA-204 on acute lung injury of rats with sepsis by targeting thioredoxin interacting protein[J].Journal of Xinxiang Medical University,2021,38(3):612.[doi:10.7683/xxyxyxb.2021.07.003]
[5]杨蕊萍,钟　武.巨噬细胞极化相关差异基因的筛选及其在脓毒症中的潜在治疗价值[J].新乡医学院学报,2019,36(2):147.[doi:10.7683/xxyxyxb.2019.02.011]
　YANG Rui-ping,ZHONG Wu.Screening of differentially expressed genes related to macrophage polarization and its potential therapautic ralue in sepsis[J].Journal of Xinxiang Medical University,2019,36(3):147.[doi:10.7683/xxyxyxb.2019.02.011]
[6]吴述光,侯小丽,马胜喜.重症肺炎并发脓毒症患者血清高迁移率族蛋白B1检测的临床意义[J].新乡医学院学报,2018,35(2):143.[doi:10.7683/xxyxyxb.2018.02.016]
　WU Shu-guang,HOU Xiao-li,MA Sheng-xi.Clinical significance of high mobility group protein B1 in patients with severe pneumonia complicated with sepsis[J].Journal of Xinxiang Medical University,2018,35(3):143.[doi:10.7683/xxyxyxb.2018.02.016]
[7]李福照.降钙素原临床应用研究进展[J].新乡医学院学报,2017,34(8):776.[doi:10.7683/xxyxyxb.2017.08.031]
[8]李亚萍,张俊林.降钙素原、胆碱酯酶及心肌肌钙蛋白I在脓毒症患者病情及预后评估中的应用价值[J].新乡医学院学报,2017,34(12):1111.[doi:10.7683/xxyxyxb.2017.12.017]
　LI Ya-ping,ZHANG Jun-lin.Application value of procalcitonin，cholinesterase and cardiac troponin I in the evaluation of disease degree and prognosis of sepsis patients[J].Journal of Xinxiang Medical University,2017,34(3):1111.[doi:10.7683/xxyxyxb.2017.12.017]
[9]王玉,宋会杰,吴方方,等.益生菌对脓毒症患儿外周血淋巴细胞焦亡的影响及机制[J].新乡医学院学报,2023,40(6):523.[doi:10.7683/xxyxyxb.2023.06.004]
　WANG Yu,SONG Huijie,WU Fangfang,et al.Effect and mechanism of probiotics on pyroptosis of peripheral lymphocytes in children with sepsis[J].Journal of Xinxiang Medical University,2023,40(3):523.[doi:10.7683/xxyxyxb.2023.06.004]
[10]李堤,王建刚,刘新宇.阿魏酸哌嗪预处理对脓毒症大鼠急性肾损伤的保护作用及机制[J].新乡医学院学报,2023,40(12):1101.[doi:10.7683/xxyxyxb.2023.12.001]
　LI Di,WANG Jiangang,LIU Xinyu.Protective effect and mechanism of piperazine ferulate pretreatment on acute kidney injury of rats with sepsis[J].Journal of Xinxiang Medical University,2023,40(3):1101.[doi:10.7683/xxyxyxb.2023.12.001]

更新日期/Last Update: 2018-03-05